SCHEMBL17440176

SCHEMBL17440176

NOC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@@H](O)[C@@H]1O

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA1 P30542 3/20 0.76
▸ SMN1; SMN2 Q16637 3/20 0.76
▸ ADORA3 P0DMS8 2/20 0.76
▸ ADORA2A P29274 2/20 0.76
▸ ADORA2B P29275 2/20 0.76
▸ DPP4 P27487 1/20 0.76
▸ MEN1 O00255 1/20 0.76
▸ SLC28A1 O00337 1/20 0.76
▸ MAP3K7 O43318 1/20 0.76
▸ SLC28A2 O43868 1/20 0.76
▸ GAPDH P04406 1/20 0.76
▸ MAPK1 P28482 1/20 0.76
▸ STAT6 P42226 1/20 0.76
▸ PI4KA P42356 1/20 0.76
▸ KMT2A Q03164 1/20 0.76
▸ PI4K2B Q8TCG2 1/20 0.76
▸ DOT1L Q8TEK3 1/20 0.76
▸ SLC29A1 Q99808 1/20 0.76
▸ PI4K2A Q9BTU6 1/20 0.76
▸ SLC28A3 Q9HAS3 1/20 0.76

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL481524 1.00 ADORA1 (0.76) ADORA1SMN1; SMN2ADORA3ADORA2AADORA2B
SCHEMBL2040670 1.00 ADORA1 (0.76) ADORA1SMN1; SMN2ADORA3ADORA2AADORA2B
SCHEMBL10997946 0.91 ADORA1 (0.76) ADORA1SMN1; SMN2ADORA3ADORA2AADORA2B
SCHEMBL7803298 0.91 ADORA1 (0.76) ADORA1SMN1; SMN2ADORA3ADORA2AADORA2B
SCHEMBL12963362 0.91 ADORA1 (0.76) ADORA1SMN1; SMN2ADORA3ADORA2AADORA2B
SCHEMBL5024895 0.91 ADORA1 (0.76) ADORA1SMN1; SMN2ADORA3ADORA2AADORA2B
SCHEMBL15788449 0.89 ADORA1 (0.74) ADORA1SMN1; SMN2ADORA3ADORA2AADORA2B
SCHEMBL384075 0.89 ADORA1 (0.74) ADORA1SMN1; SMN2ADORA3ADORA2AADORA2B
SCHEMBL15338502 0.89 ADORA1 (0.74) ADORA1SMN1; SMN2ADORA3ADORA2AADORA2B
SCHEMBL41361 0.89 ADORA1 (0.74) ADORA1SMN1; SMN2ADORA3ADORA2AADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3169783-A2 TERMINAL MODIFICATIONS OF POLYNUCLEOTIDES Modernatx, Inc. (US) 2017-05-24 — — EP disclosed
WO-2016011306-A2 TERMINAL MODIFICATIONS OF POLYNUCLEOTIDES MODERNA THERAPEUTICS, INC. (US) 2016-01-21 — — WO disclosed
Send feedback